4225 EXECUTIVE SQUARE, LA JOLLA, CA
Investor Presentation
Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Zura Bio Limited Approves Amended 2023 Equity Incentive Plan
Director Resignation - Someit Sidhu Steps Down from Zura Bio Board
Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Annual Report to Security Holders
CFO Departure - Eric Hyllengren Separated from Zura Bio Limited
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence